Trial intelligence / Profile preview

Piminxiao Capsule plus levocetirizine for chronic spontaneous urticaria

ChiCTR2200058439Phase 4Not yet recruiting

Sponsor
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Start
Apr 2022
Countries
1
01

Overview

Phase 4, randomised trial of Piminxiao Capsule in chronic idiopathic urticaria (CIU) (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Urticaria Activity Score (UAS). Planned start Apr 2022; status: not yet recruiting.

02

Drugs

Piminxiao Capsule
03

Conditions

chronic idiopathic urticaria (CIU)

Beyond the preview

Go deeper on ChiCTR2200058439.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200058439.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call